A multicentre, phase III clinical trial of secretin* for the treatment of paediatric autism has failed to meet its dual primary endpoints
Keyword(s):
Keyword(s):
2007 ◽
Vol 57
(6)
◽
pp. 501
Keyword(s):
Keyword(s):